ArticleInternational urology and nephrology1995
A new procedure to evaluate the inhibitory capacity of calcium oxalate crystallization in whole urine.
Article in International urology and nephrology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronopharmacological studies on potassium citrate treatment of oxalocalcic urolithiasis.International urology and nephrology · 1997Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A procedure to evaluate the global inhibitory capacity of heterogeneous nucleation for a given urine without any modification of its composition was developed. The procedure is based on the use of flat solid substrates that are submerged in urine. The quantification of the amount of formed crystals on the substrate permits to evaluate the crystallization inhibitory capacity for a whole urine. The proposed method was applied to study the inhibitory capacity of urines belonging to stone-formers and healthy people, before and after the ingestion of a dietary complement containing phytate in order to prove its reliability. A clear increase of the inhibitory capacity of the urine was detected in most cases when the dietary complement was consumed. Moreover, lack of crystallization inhibitory capacity was more frequent in stone-formers than in healthy people.
Indexed as
Identifiers
8725028What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.